Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.
GLOBAL — Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.
Image source: Investor's Business Daily
This report draws on reporting from Investor's Business Daily. DOCFLiX Desk has verified and adapted this report with additional context for our readers.
Read Original Story ↗